Citadel Advisors »

Nervgen Pharma Ord shares owned by Citadel Advisors

Quarter-by-quarter ownership of Nervgen Pharma Ord (NGEN) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Nervgen Pharma Ord

Tip: Access up to 7 years of quarterly data

All positions including Nervgen Pharma Ord held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nervgen Pharma Ord by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $57k 28k 2.06

More positions owned by Citadel Advisors

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Micron Technology Call Option (MU)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Sandisk Corp (SNDK)
Advanced Micro Devices Call Option (AMD)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Amazon (AMZN)

View all positions for Citadel Advisors

Top funds holding Nervgen Pharma Ord

Empery Asset Management
Rock Springs Capital Management
DAFNA Capital Management
Ghisallo Capital Management
Armistice Capital
LMR Partners
Marshall Wace
UBS Group
Stonepine Capital Management
Jane Street
Woodline Partners
PFG Investments
Susquehanna International
Bank of America Corporation
Royal Bank of Canada

View all funds holding Nervgen Pharma Ord